1. anonymous. Statistical aspects of the design, analysis, and interpretation of chronic rodent carcinogenicity studies of pharma-ceuticals. Technical report, US FDA CDER.
2. anonymous. Guidelines for carcinogen risk assessment. EPA (1986) U.S. Environmental Protection Agency, RiskAssessment Forum, Washington, DC., 1986.
3. anonymous. Toxicology and carcinogenesisstudies of methyleugenol in f344/n rats and b6c3f1 mice. technical report, 2000, technicalreport 491. National Toxicology Program, 2000.
4. The p-value interval as an inferential tool;Journal of the Royal Statistical Society: Series D (The Statistician),2001
5. Accounting for Multiplicities in Assessing Drug Safety: A Three-Level Hierarchical Mixture Model